Nivolumab plus ipilimumab and live bacteria supplements in advanced kidney cancer
Researchers are interested in the bacteria in our gut (the [...]
ASCO 2021: Gut microbiome boosts nivolumab/ipilimumab activity
Recent evidence suggests that the bacteria in the gut (the [...]
Probiotic supplements and improves clinical benefit in kidney cancer
This prospective, randomised study in 20 people looked at the [...]
Bacteria in the gut linked to efficacy of immunotherapy
In this study, the investigators looked at the different types [...]
